头颈癌幸存者远程医疗照护的可行性与成本:一项系统综述
该研究系统检索了2005至2021年间关于头颈癌幸存者远程医疗照护模式的同行评议可行性研究,共纳入38项研究。患者入组率范围为20.8%至85.7%,脱落率范围为7%至47.7%;干预组总体依从性较对照组高30.2%(46.8% vs 16.6%)。有成本分析的研究发现远程医疗模式显著更便宜且更具成本效益,每名患者节省642.30美元(n=3),每次就诊平均节省7个工作日。
要点
- 远程医疗幸存者照护项目可行且具成本效益,并与患者结局改善相关。
- 干预组总体依从性较对照组高30.2%(46.8% vs 16.6%)。
- 每名患者节省642.30美元(n=3),每次就诊平均节省7个工作日。
核心结论
- 远程医疗幸存者照护项目可行且具成本效益,并与患者结局改善相关,但可能并非适合每位患者。
- 鉴于研究设计、报告、测量指标和方法学质量的变异性,需进一步研究以理解远程医疗在幸存者照护中的作用。
研究设计与样本
- 系统综述,检索Ovid MEDLINE、Embase、Scopus、CINAHL数据库。
- 系统检索2005至2021年间发表的关于头颈癌幸存者远程医疗照护模式的同行评议可行性研究,检索词为「头颈癌」和「远程医疗」及其同义词。
- 纳入标准为针对头颈癌患者的远程医疗幸存者照护项目干预研究,且报告定量可行性结局指标(如入组率、保留率、脱落率、依从性/任务完成率、患者满意度、成本)。
- 共识别1557项研究,其中38项符合纳入标准并纳入分析。
主要发现
- 患者入组率范围为20.8%至85.7%,脱落率范围为7%至47.7%。
- 干预组总体依从性较对照组高30.2%(46.8% vs 16.6%)。
- 有成本分析的研究发现远程医疗照护模式在统计学上显著更便宜且更具成本效益,每名患者节省642.30美元(n=3)。
- 远程医疗模式还大幅减少了每次就诊的工作时间,平均每次就诊节省7天。
关键数值与推荐
- 可行性结局包括入组率和脱落率、依从性/任务完成率、患者满意度以及不同幸存者照护领域的用户反馈调查。
- 患者入组率范围为20.8%至85.7%。
- 脱落率范围为7%至47.7%。
- 干预组总体依从性为46.8%,对照组为16.6%,干预组较对照组高30.2%。
- 每名患者节省642.30美元(n=3)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究设计、报告、测量指标和方法学质量存在变异性。
- 需进一步研究以理解远程医疗在幸存者照护中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Evaluate the feasibility and cost-effectiveness of telehealth head and neck cancer (HNC) survivorship care. DATA SOURCES: Ovid MEDLINE, Embase, Scopus, CINAHL. REVIEW METHODS: A systematic search for peer-reviewed feasibility studies on telehealth models for HNC survivorship care published between 2005 and 2021 was conducted using the terms "head and neck cancer" and "telehealth" and their synonyms. Inclusion criteria were studies on telehealth survivorship program interventions for HNC patients with quantitative feasibility outcome measures (eg, enrollment, retention, attrition/dropout rate, adherence/task completion rate, patient satisfaction, cost). RESULTS: Thirty-eight studies out of 1557 identified met inclusion criteria and were included for analysis. Feasibility outcomes evaluated were enrollment and attrition rates, adherence/task completion rates, patient satisfaction, and user feedback surveys in different survivorship domains. Patient enrollment ranged from 20.8% to 85.7%, while attrition ranged from 7% to 47.7%. Overall, adherence was 30.2% higher in the intervention group than in the control group (46.8% vs 16.6%). Studies with cost analysis found telehealth models of care to be statistically significantly less expensive and more cost-efficient than the standard model of care, with a $642.30 saving per patient (n = 3). Telehealth models also substantially reduced work time saving per visit (on average, 7 days per visit). CONCLUSION: While telehealth survivorship programs are feasible and cost-effective and are associated with improved patient outcomes, they might not be ideal for every patient. Further investigations are needed to understand the role of telehealth in survivorship care, given the variability in study design, reporting, measures, and methodological quality.
引用
- De Ravin E, Armache M, Campbell F, et al. Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review. Otolaryngol Head Neck Surg. 2023. PMID: 36939546. doi:10.1002/ohn.213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。